MEADE HARRY 4
4 · GTC BIOTHERAPEUTICS INC · Filed Feb 5, 2009
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Award
Common Stock
2009-01-02+5,400→ 170,212 total
Holdings
- 53,028(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents shares of the Issuer's Common Stock issuable upon conversion of restricted stock units granted on January 2, 2009 pursuant to the Issuer's 2008 Retention Incentive Plan and issued under the Issuer's 2002 Equity Incentive Plan, as amended and restated. The restricted stock units will vest and settle on July 30, 2009.